GLP1R and Alzheimer disease: Studies (Ali et al., 2024) have suggested that NEPI might offer protective effects against the development of AD by increasing the levels of GLP-1, neuropeptide Y (NPY), and substance P. However, NEPI might contribute to AD development by increasing levels of BK and NPs (Bavishi et al., 2015).